Bristol Myers Squibb: Pharma And Government Playing ‘Chicken’ Over New Drug Pricing (BMY)

Dollar bill and doctor prescription with pills lie on doctor table in clinic closeup

Nadzeya Haroshka

Investment Overview – BMY’s Middling Position Within Big Pharma Industry

Bristol Myers Squibb (NYSE:BMY) is the US’ seventh largest pharmaceutical company by market cap, which stands at $123bn at the time of writing, with shares priced at ~$59 – down 27% from their all-time

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *